How to Take Tamiflu: Dosage for Adults and Kids

Tamiflu (oseltamivir) is taken as 75 mg twice a day for five days in adults and adolescents 13 and older, while children’s doses are calculated by body weight. The drug works best when started within 48 hours of the first flu symptoms, and taking it with food makes a real difference in how well you tolerate it. Below is everything you need to know about dosing for different ages, what to do if you miss a dose, and the practical details that determine whether the medication actually helps.

Standard Adult Dosage

For treating influenza in adults and teens aged 13 and up, the standard regimen is one 75 mg capsule taken twice daily for five days. You take one capsule in the morning and one in the evening, roughly 12 hours apart. This dosing schedule was established in clinical trials involving healthy adults and high-risk patients and has remained the recommended treatment regimen since the drug’s approval.¹

When Tamiflu is prescribed for prevention rather than treatment, such as after a known exposure to someone with the flu, the dose drops to 75 mg once daily, and the course typically lasts 10 days or for the duration of community outbreak exposure. The prophylactic dose is the same pill, just taken half as often.

Dosing for Children by Weight

Children’s Tamiflu doses are tied to body weight rather than age alone, which is an important distinction because two kids the same age can be very different sizes. The weight-based breakdown for children aged one through 12 looks like this:

15 kg or less: 30 mg twice daily
15 to 23 kg: 45 mg twice daily
23 to 40 kg: 60 mg twice daily
Over 40 kg: 75 mg twice daily (adult dose)

These tiers were developed through pharmacokinetic studies that measured how children’s bodies absorb and clear the drug’s active form.² Like adults, children take each dose twice a day for five days. Children who can’t swallow capsules should use the oral suspension, which comes in a concentration of 6 mg/mL. Your pharmacist will calculate the volume per dose based on your child’s weight.

Infants Under One Year

Dosing gets more nuanced for babies. Infants younger than 12 months metabolize oseltamivir differently from older children, so researchers studied them in narrow age bands. A dose of 3 mg/kg twice daily consistently produced the right drug levels in infants from birth through eight months of age, though babies under three months showed more variability in how they processed the drug.³ For infants nine through 11 months, a slightly higher dose of 3.5 mg/kg twice daily was needed to reach the target range.²

One finding that matters for parents of toddlers: in the same study, six out of ten children aged 12 to 23 months who received the standard 30 mg unit dose had drug levels below the target range.³ This suggests that some toddlers near the lower weight boundary may not be getting enough of the drug at the flat 30 mg dose. If your child is in this age group, it’s worth making sure the prescriber has considered actual body weight rather than just defaulting to the age-based recommendation.

Why the 48-Hour Window Matters

You’ll hear repeatedly that Tamiflu should be started within 48 hours of symptom onset, and the clinical data back this up. In a randomized placebo-controlled trial, people who started oseltamivir within 48 hours had a shorter illness, with a median symptom duration of about three days compared with four days in the placebo group. But when treatment was started 48 hours or longer after symptoms began, the difference between the drug and placebo largely disappeared.⁴

That said, “within 48 hours” is a guideline, not a hard cutoff. For people at high risk of complications, such as those who are hospitalized, elderly, pregnant, or immunocompromised, doctors often prescribe Tamiflu even beyond the 48-hour window. The drug may still help reduce severe outcomes in these groups, even if the benefit for symptom duration shrinks. The bottom line for most healthy people: call your doctor or get a prescription as soon as you suspect flu, because every hour you wait chips away at how much the drug can do.

Taking Tamiflu with Food

Nausea and vomiting are the most common side effects, and they’re significantly less likely when you take the capsule with food. Clinical trials found that administering oseltamivir with a meal reduced gastrointestinal side effects to roughly 10 percent of patients.⁵ This is not just a comfort measure. If you vomit shortly after taking a dose, you may not absorb enough of the medication. Eating something before or alongside the capsule, even just a few crackers or a piece of toast, can make a meaningful difference.¹

For children on the liquid suspension, the same advice applies. A small snack before the dose helps. If a child vomits within an hour of taking the medication, it’s generally reasonable to give a repeat dose, but check with your pharmacist or pediatrician first.

What to Do About Missed Doses

If you realize you’ve missed a dose and fewer than 12 hours have passed since it was due, take it as soon as you remember. If 12 or more hours have elapsed, skip the missed dose entirely and take the next one at its regularly scheduled time.⁶ Don’t double up to compensate. Taking two doses close together increases the risk of nausea without improving efficacy.

Dose Adjustments for Kidney Problems

Oseltamivir is cleared through the kidneys, so people with reduced kidney function need adjusted doses to avoid the drug building up in their system. For treatment, the adjustments look roughly like this: people with moderate kidney impairment take 30 mg twice daily, and those with severe impairment take 30 mg once daily. People with mild impairment generally don’t need any adjustment.⁷

There’s a catch, though. A review of the evidence found that the standard dose-reduction approach focused too heavily on matching long-term steady-state drug levels to those of healthy patients, without paying enough attention to whether therapeutic levels are reached early in the infection when the drug does the most good. The authors argued that current dosing advice for mild-to-moderate kidney impairment and for people with larger body mass may actually reduce or even negate the drug’s benefit.⁸ If you have kidney disease, your prescriber should know your most recent kidney function numbers when choosing the dose. For patients on dialysis, the situation is more complex and typically requires specialist guidance.

Liquid Formulation and Compounding

Tamiflu comes in both capsule and oral suspension forms. The commercially manufactured suspension has a concentration of 6 mg/mL and is the standard form for young children. However, there are times, especially during flu outbreaks, when the liquid runs out of stock. When that happens, pharmacists can compound an oral liquid from the capsule contents. Standardized methods exist for preparing a 15 mg/mL oseltamivir suspension using common pharmacy vehicles like cherry syrup, and stability testing has confirmed these compounded preparations hold up well during a course of treatment.⁹

If your pharmacist prepares a compounded liquid, the concentration will be different from the commercial product, so make sure you receive clear instructions about the exact volume per dose. A dosing syringe marked in milliliters is far more reliable than a kitchen teaspoon. Store the compounded suspension in the refrigerator and shake it before each use.

Side Effects Beyond Nausea

Aside from nausea and vomiting, headache is the next most frequently reported side effect. In clinical trials, headaches, nausea, and vomiting all occurred more often in people taking oseltamivir than in those on placebo.⁵ These tend to be mild and short-lived, usually concentrated in the first day or two of treatment. Serious allergic reactions are rare but possible and would include swelling of the face or throat, difficulty breathing, or a severe skin rash. Stop taking the drug and seek immediate care if you experience any of these.

The Neuropsychiatric Question

Reports from Japan in the mid-2000s raised concern about unusual behavioral side effects in children and teenagers taking Tamiflu, including confusion, hallucinations, and self-harm. This led to years of investigation and a black-box-style warning in some countries. The picture that has emerged since then is more reassuring than alarming, but it’s not perfectly settled.

A large recent study of nearly 700,000 children found that rates of serious neuropsychiatric events were actually lower during periods of oseltamivir-treated influenza than during untreated influenza, with the effect driven primarily by a reduction in neurologic events rather than psychiatric ones.¹⁰ A systematic review and meta-analysis similarly found that oseltamivir was associated with a lower overall incidence of neuropsychiatric events, with a risk ratio of 0.83, except in patients younger than 20.¹¹

That exception for younger patients is where it gets complicated. A nationwide population-based study found the highest increased risk of neuropsychiatric adverse events in adolescents aged 10 to 19, with an adjusted odds ratio of 2.27 compared to periods when the same patients were not taking the drug.¹² The difficulty is untangling whether the drug caused these events or whether influenza itself, which is known to cause delirium and encephalopathy, was the real culprit. Flu can make children and teenagers act confused or agitated even without any medication.

The practical takeaway: the evidence does not support withholding Tamiflu from children who need it, but it’s reasonable to keep a closer eye on children and adolescents during treatment. Watch for unusual behavior, confusion, agitation, or self-harm impulses, and contact a doctor immediately if any of these appear.

Tamiflu During Pregnancy and Breastfeeding

Influenza during pregnancy poses real risks, including preterm delivery and pneumonia, so treatment is recommended. Animal studies and toxicology data have not shown harmful effects on fetal development at clinically relevant doses, and transfer of the drug across the placenta was very limited in an experimental human placenta model. In a review of 232 maternal exposures tracked by the manufacturer, the rates of spontaneous miscarriage, therapeutic termination, and preterm delivery were not higher than background rates in the general population.¹³

The data remain limited simply because pregnant women are not enrolled in large randomized trials. But the weight of available evidence, combined with the known dangers of untreated flu in pregnancy, is why health authorities consistently recommend oseltamivir for pregnant women with suspected or confirmed influenza. The standard adult dose of 75 mg twice daily for five days applies. Small amounts of oseltamivir do pass into breast milk, but the levels are low and breastfeeding is generally considered compatible with treatment.

Tamiflu and Flu Vaccines

If you’re taking Tamiflu and also due for a flu shot, the type of vaccine matters. Standard injectable flu vaccines (the inactivated kind) are fine to receive during or right after a Tamiflu course. The nasal spray vaccine (LAIV) is different: because it contains live attenuated virus, Tamiflu could potentially interfere with the vaccine’s ability to produce an immune response. The Advisory Committee on Immunization Practices notes that antiviral agents might reduce the effectiveness of the live nasal spray vaccine if given from 48 hours before to 14 days after vaccination.¹⁴ If you recently took Tamiflu and need to be vaccinated, the injectable shot avoids this concern entirely.

How Tamiflu Compares to Newer Alternatives

Baloxavir marboxil (brand name Xofluza) is the main newer alternative. Its biggest selling point is convenience: one single dose and you’re done, compared with Tamiflu’s ten doses over five days. Baloxavir works by a completely different mechanism, targeting the virus’s ability to replicate its genetic material rather than blocking its release from cells the way oseltamivir does.

In clinical trials, baloxavir reduced viral loads faster than oseltamivir, though the time to overall symptom resolution was similar between the two drugs.¹⁵ In children specifically, a meta-analysis found baloxavir shortened fever duration by about 13 hours compared with oseltamivir, with no meaningful difference in overall symptom resolution and potentially fewer episodes of nausea and vomiting.¹⁶ So if stomach upset is a concern or you’re worried about completing a full five-day course, baloxavir may be worth discussing with your doctor. Oseltamivir remains the most studied and widely used option, with a longer track record across different patient populations including very young infants and pregnant women.

Antiviral Resistance

One concern with any antiviral drug is that the virus can develop resistance. For oseltamivir, the most well-known resistance mechanism involves a mutation called H275Y in the neuraminidase protein, the viral enzyme the drug targets. Surveillance data from 2014 through 2021 estimated that this mutation was present in about 0.27 percent of circulating H1N1 strains, so resistance remains uncommon but not nonexistent.¹⁷

Resistance mutations tend to come at a cost to the virus. The H275Y change typically makes the virus less fit, meaning it replicates less efficiently and doesn’t spread as well. The historical exception was a seasonal H1N1 strain around 2007-2008 that acquired additional “permissive” mutations restoring the virus’s fitness even with the resistance change, allowing it to spread widely.¹⁸ More recently, researchers have identified a new resistance mechanism in a different viral protein (hemagglutinin) that can confer oseltamivir resistance independently of neuraminidase mutations.¹⁹ This finding underscores why continuous surveillance of flu strains matters, though for any individual patient taking Tamiflu as prescribed, the chance of encountering a resistant virus remains very low.

Stockpiling and Shelf Life

Many countries stockpiled large quantities of Tamiflu in preparation for pandemic flu. A practical question that arose was whether the capsules remained effective beyond their labeled expiration date. Testing of stockpiled oseltamivir found that the drug retained its potency, as defined by pharmacopeial acceptance standards, past the printed expiration date.²⁰ This has practical relevance for government pandemic readiness, though for household use you should still follow the labeled expiration date and store capsules at room temperature away from moisture. The oral suspension, whether commercial or compounded, has a much shorter shelf life and should be refrigerated, with the compounded version typically used within a couple of weeks.